Professor of Medicine and Physiology
Ph.D., Department of Animal Science, The Hebrew University of Jerusalem, Israel
Yaccoby S, Wezeman MJ, Henderson A, Fox MH, Qing Y, Barlogie B, Epstein J: Cancer and the microenvironment: Myeloma-osteoclast interactions as a model. Cancer Res. 64: 2016-2023, 2004. PMID: 15026338
Yaccoby S, Ling W, Zhan F, Walker R, Barlogie B, Shaughnessy, JD Jr: Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple growth in-vivo. Blood 109:2106-11, 2007. PMID: 17068150
Li X, Pennisi A, and Yaccoby S. Role of decorin in the antimyeloma effect of osteoblasts. Blood 112:159-168, 2008. PMID: 18436739
Pennisi A, Li X, Ling W, Khan S, Zangari M, Yaccoby S. The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo. Am J Hematol. 84:6-14, 2009. PMID: 18980173
Pennisi A, Ling W, Li X, Khan S, Shaughnessy JD, Barlogie B, Yaccoby S. The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth. Blood. 114:1803-1812, 2009. PMID: 19597185.
Yaccoby S. Advances in the understanding of myeloma bone disease and tumour growth. Br J Haematol, 149:311-321, 2010. Invited Review. PMID: 20230410
Yaccoby S. Role of proteasome in bone formation and osteoclastogenesis. IBMS BoneKEy. April;7(4):147-55, 2010. Invited Perspective.